LLY
Lilly(Eli)
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: LLY
- PE Ratio
The PE ratio for Lilly(Eli) stock stands at 40.72 as of Aug 11, 2026. This is calculated based on the current EPS of $29.84 and the stock price of $1,215.02 per share. An increase of 3.9% has been seen in the P/E ratio compared to the average of 39.2 of the last 4 quarters.
LLY PE ratio history
Over the last ten years, the average PE ratio of Lilly(Eli) has been 52.41. The current 40.72 PE ratio is 22% below the historical average. Over the past ten years, LLY's PE ratio was at its highest in the Sep 2018 quarter at 228.32, with a price of $107.31 and an EPS of $0.47. The Sep 2019 quarter recorded the bottom point at 13.57, with a price of $111.83 and an EPS of $8.24.
Lilly(Eli) PE ratio by year
Maximum annual increase: 162.65% in 2014
Maximum annual decrease: -60.05% in 2019
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 46.73 | -28.82% | $1,074.68 | $23 |
| 2024 | 65.65 | -34.45% | $772 | $11.76 |
| 2023 | 100.16 | 89.73% | $582.92 | $5.82 |
| 2022 | 52.79 | 17.55% | $365.84 | $6.93 |
| 2021 | 44.91 | 81.38% | $276.22 | $6.15 |
| 2020 | 24.76 | 68.21% | $168.84 | $6.82 |
| 2019 | 14.72 | -60.05% | $131.43 | $8.93 |
| 2018 | 36.85 | N/A | $115.72 | $3.14 |
| 2017 | N/A | N/A | $84.46 | -$0.19 |
| 2016 | 28.4 | -23.49% | $73.55 | $2.59 |
| 2015 | 37.12 | 19.97% | $84.26 | $2.27 |
| 2014 | 30.94 | 162.65% | $68.99 | $2.23 |
| 2013 | 11.78 | -12.35% | $51 | $4.33 |
| 2012 | 13.44 | 26.08% | $49.32 | $3.67 |
| 2011 | 10.66 | 39.35% | $41.56 | $3.9 |
Lilly(Eli) PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2026 | 40.2 | 23.2% | $1,199.43 | $29.84 |
| Mar 2026 | 32.63 | -30.17% | $919.77 | $28.19 |
| Dec 2025 | 46.73 | 25.48% | $1,074.68 | $23 |
| Sep 2025 | 37.24 | -26.66% | $763 | $20.49 |
| Jun 2025 | 50.78 | -24.13% | $779.53 | $15.35 |
| Mar 2025 | 66.93 | 1.95% | $825.91 | $12.34 |
| Dec 2024 | 65.65 | -31.16% | $772 | $11.76 |
| Sep 2024 | 95.36 | -14.16% | $885.94 | $9.29 |
| Jun 2024 | 111.09 | -2.61% | $905.38 | $8.15 |
| Mar 2024 | 114.07 | 13.89% | $777.96 | $6.82 |
| Dec 2023 | 100.16 | 3.31% | $582.92 | $5.82 |
| Sep 2023 | 96.95 | 49.04% | $537.13 | $5.54 |
| Jun 2023 | 65.05 | 19.53% | $468.98 | $7.21 |
| Mar 2023 | 54.42 | 3.09% | $343.42 | $6.31 |
| Dec 2022 | 52.79 | 9.05% | $365.84 | $6.93 |
LLY Price vs fair value
LLY average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
LLY's current P/E ratio is below the 3, 5 and 10-year averages.
PE comparison
Lilly(Eli)'s P/E of 40.72 is above the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 25.05, Lilly(Eli)'s P/E is 63% higher.
LLY PE vs peers
Frequently asked questions
What is Lilly(Eli)'s PE ratio?
The price to earnings ratio for LLY stock is 40.72 as of Aug 11, 2026.
What is the 3-year average PE ratio for Lilly(Eli) (LLY)?
As an average over the last 3 years, LLY stock has a PE ratio of 71.48.
What is the 5-year average PE ratio for Lilly(Eli) (LLY)?
As an average over the last 5 years, LLY stock has a PE ratio of 62.62.
What is the highest PE ratio for LLY?
The highest quarterly PE ratio in the last ten years has been 228.32 and it was in the Sep 2018 quarter.
How does the current PE ratio for LLY compare to its historical average?
The current price to earnings ratio of LLY is 22% lower than the 10-year historical average.
How is LLY's PE ratio calculated (Lilly(Eli) PE ratio formula)?
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Aug 11, 2026), Lilly(Eli)'s stock price is $1,215.02. The earnings per share for the trailing twelve months (TTM) ending Jun 2026 is $29.84. Therefore, Lilly(Eli)'s P/E ratio for today is 40.72. PE RATIO(40.72) = STOCK PRICE($1,215.02) / TTM EPS($29.84)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.